Drug Database
Back to search

Belgium· BE-AMP-SAM287411-00

Evoltra 1 mg/ml

A clofarabine product containing clofarabine, registered in Belgium by Sanofi. The same ATC class is registered in 15 of our 19 countries.

ATC L01BB06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedEvoltra 1 mg/mlATCL01BB06REGISTER NO.BE-AMP-SAM287411-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clofarabineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Clofarabine is registered in 15 of 19 countries.

Countries holding a registration under ATC L01BB06 (clofarabine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search clofarabine products by name

Clofarabine · ATC L01BB06

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Clofarabine
Manufacturer
Sanofi
Country
Belgium (BE)
ATC code
L01BB06
ATC class
Clofarabine
Defined daily dose
8.8 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0789164
  • be_apb
    2672525

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

530 interactions on record for clofarabine.

Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check clofarabine against other medicinesHow interaction checks work

Clofarabine · interactions on record

530 records

  • 41 severe
  • 445 moderate
  • 12 minor
  • 32 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • CidofovirJ05AB12severe
  • ClotrimazoleA01AB18moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Clofarabine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clofarabine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Clofarabin Koanaa
  • Bulgaria · Клофарабин Зентива
  • Germany · Clofarabin Ratiopharm
  • Spain · Clofarabin Teva, Clofarabina Accord
  • France · Clofarabine Accord, Clofarabine Tillomed
  • United Kingdom (Northern Ireland) · Clofarabine Sandoz
  • Greece · Ebroka
  • Iceland · Evoltra
  • Italy · Clofarabina Medac
  • Liechtenstein · Evoltra
  • Netherlands · Clofarabine Accord, Clofarabine Genthon
  • Norway · Evoltra
  • Poland · Clofarabine Norameda, Clofarabine Vivanta
  • Portugal · Clofarabina Accord, Clofarabina Vivanta
  • Romania · Clofarabină Vivanta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/74e71692-8fe8-4281-b0c5-5bba018b989c
GET /v1/drugs/74e71692-8fe8-4281-b0c5-5bba018b989c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Evoltra 1 mg/ml",
  "name_fr": "Evoltra 1 mg/ml",
  "name_nl": "Evoltra 1 mg/ml",
  "amp_code": "SAM287411-00",
  "strengths": [
    "1.0000",
    "1.0000",
    "1.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Clofarabine",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Clofarabine",
  "authorisation_numbers": [
    "EU/1/06/334/001",
    "EU/1/06/334/002",
    "EU/1/06/334/003",
    "EU/1/06/334/005"
  ]
}
API referenceMCP serverPlans

See everything about clofarabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console